At Salix, we are committed to providing products that prevent or treat gastrointestinal (GI) disorders.
Salix Pharmaceuticals, headquartered in Raleigh, North Carolina, is a specialty pharmaceutical company committed to advancing the treatment of many chronic gastrointestinal disorders. For more than 20 years, we have licensed, developed, and marketed innovative products to provide healthcare professionals and patients with effective solutions for the management of some of the most chronic and debilitating conditions. Salix currently markets its product line through dedicated, specialty sales groups to U.S. healthcare providers in the areas of gastroenterology, hepatology, colorectal surgery, endocrinology, internal medicine, primary care, infectious disease, allergy/immunology, and pediatric urology.
GI disorder treatments
METOZOLV® ODT (metoclopramide HCl) 5 mg orally disintegrating tabletsPrescribing Information, including BOXED WARNING
MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) 100 g/7.5 g/2.691 g/1.015 g/5.9 g/4.7 g for oral solutionPrescribing Information
OSMOPREP® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) tabletsPrescribing Information, including BOXED WARNING
Other Salix products
The information contained on this page is intended for US residents, healthcare providers, and pharmacists only.